Stephan Tyler
About Stephan Tyler
Stephan Tyler is the Director of Market Access DACH at Insmed Incorporated, with extensive expertise in Swiss healthcare systems and pharmaceutical markets. He has a background in biochemistry and health technology assessment, and has held various positions in market access and pricing across several major pharmaceutical companies.
Work at Insmed
Stephan Tyler has been serving as the Director Market Access DACH at Insmed Incorporated since 2019. His role is based in Frankfurt am Main und Umgebung, Deutschland. In this position, he focuses on market access strategies within the DACH region, leveraging his extensive knowledge of the Swiss healthcare system and pharmaceutical markets.
Education and Expertise
Stephan Tyler studied at Freie Universität Berlin, where he earned a Diplom in Biochemie from 2007 to 2012. He furthered his education at Technische Universität Berlin, completing a program in Health Technology Assessment (HTA) from 2014 to 2015. His academic background supports his expertise in various healthcare domains, including oncology, immunology, respiratory care, neurology, and transplants.
Background
Before joining Insmed, Stephan Tyler held several positions in market access and pricing within the pharmaceutical industry. He worked at GSK as a Market Access Manager from 2012 to 2014, at Novartis as a Pricing & Reimbursement Manager from 2014 to 2015, at AstraZeneca as a Market Access Manager from 2015 to 2016, and at Pfizer as Manager Access Oncology from 2016 to 2019.
Achievements
Stephan Tyler possesses specialized knowledge in payer negotiation strategies and has demonstrated skills in project management and communication within the healthcare sector. His experience across multiple leading pharmaceutical companies has equipped him with a comprehensive understanding of market access challenges and strategies.